GNS Healthcare, a precision medicine AI company, has extended its Series D funding round, bringing the amount raised to $28 million. The latest investor was Merck Global Health Innovation Fund.
Source: Press Release
Merck backs GNS Healthcare
GNS Healthcare, a precision medicine AI company, has extended its Series D funding round, bringing the amount raised to $28 million.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: